Effect of prior cancer on survival outcomes for patients with pancreatic adenocarcinoma: a propensity score analysis.

Patients with PDAC who had a prior cancer had similar OS and cancer-specific mortality rates as those of patients without a prior cancer. The inclusion of patients with a prior cancer in the clinical trials of PDAC should be considered.